# Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-efficacy-and-safety-of-eculizumab-in-japanese-patients-with-pnh-aegis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuzuru Kanakura,Kazuma Ohyashiki,Tsutomu Shichishima,Shinichiro Okamoto,Kiyoshi Ando,Haruhiko Ninomiya,Tatsuya Kawaguchi,Shinji Nakao,Hideki Nakakuma,J Nishimura,Taroh Kinoshita,Camille L. Bedrosian,Keiya Ozawa,Mitsuhiro Omine |
| Citations | 38 |
| DOI | 10.1007/s12185-013-1404-y |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1984737284 |
| PMID | 23934275 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Yuzuru Kanakura](https://scholariq.org/researchers/yuzuru-kanakura/)
- [Taroh Kinoshita](https://scholariq.org/researchers/taroh-kinoshita/)
- [Kiyoshi Ando](https://scholariq.org/researchers/kiyoshi-ando/)
- [Keiya Ozawa](https://scholariq.org/researchers/keiya-ozawa/)
- [Shinji Nakao](https://scholariq.org/researchers/shinji-nakao/)

## Paper funders

- [Alexion Pharmaceuticals](https://scholariq.org/funders/alexion-pharmaceuticals/)
- [Japan Society for the Promotion of Science](https://scholariq.org/funders/japan-society-for-the-promotion-of-science/)

## Paper journal

- [International Journal of Hematology](https://scholariq.org/journals/international-journal-of-hematology/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.